IP Library Granted Patent US 9,121,828
Granted Patent B2
US 9,121,828 · App. 13/631,206 · Granted Sep 1, 2015

Cellular libraries of peptide sequences (CLiPS) and methods of using the same

Inventors: Patrick Sean Daugherty (Santa Barbara, CA); Kevin Todd Boulware (Pasadena, CA)
Assignee: The Regents of the University of California
G01N21/6486C12N15/1037C12N15/1044C40B40/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,121,828
App. No.
13/631,206
Granted
Sep 1, 2015
Kind
B2
Abstract

The present invention provides compositions including peptide display scaffolds that present at least one candidate peptide and at least one detectable moiety in at least one of the N-terminal and C-terminal candidate peptide presenting domains that when expressed in a cell are accessible at a surface of the cell outermembrane. In addition, the present invention also provides kits and methods for screening a library of cells presenting the candidate peptides in peptide display scaffolds to identify a ligand for an enzyme.

Claims (34)

1. A cell comprising a peptide display scaffold disposed in an outer membrane of the cell, the peptide display scaffold comprising a fusion protein comprising the formula:

[D 1 -C 1 ]-TM-[D 2 ]

wherein TM is a circularly permuted OmpA or OmpX protein;

C 1 comprises a candidate peptide; and

D 1 and D 2 are first and second detectable moieties, wherein D 1 is a heterologous peptide or polypeptide and D 2 is a heterologous peptide or polypeptide, wherein D 1 and D 2 are not the same and wherein D 1 -C 1 and D 2 are exposed at an extracellular surface of the cell outer membrane and one or both of the N- and C-termini of the fusion protein are exposed at the extracellular surface of the cell outer membrane.

2. The cell of claim 1 , wherein the fusion protein comprises at least one linker, wherein the linker is between C i and TM or between D 2 and TM.

3. The cell of claim 1 , wherein the fusion protein comprises a linker between C 1 and TM and a linker between D 2 and TM.

4. The cell of claim 1 , wherein detectable moieties D 1 and D 2 are first and second affinity tags which are not the same.

5. The cell of claim 1 , wherein C 1 comprises a member of a library of candidate peptide substrates for an enzyme.

6. The cell of claim 1 , wherein at least one of detectable moieties D 1 and D 2 is a fluorescent protein.

7. The cell of claim 1 , wherein D 1 -C 1 is located at an N-terminal domain of the fusion protein and D 2 is located at a C-terminal domain of the fusion protein.

8. The cell of claim 1 , wherein C 1 -D 1 is located at a C-terminal domain of the fusion protein and D 2 is located at an N-terminal domain of the fusion protein.

9. The cell of claim 1 , wherein the fusion protein comprises a C 2 between TM and D 2 , wherein the fusion protein comprises the formula

[D 1 -C 1 ]-TM-[C 2 -D 2 ]

wherein C 2 comprises a candidate peptide, and C 1 and C 2 are not the same, and wherein D 1 -C 1 and C 2 -D 2 are exposed at the extracellular surface of the cell outer membrane.

10. The cell of claim 9 , wherein the fusion protein comprises at least one linker, wherein the linker is between C 1 and TM or between C 2 and TM.

11. The cell of claim 9 , wherein the fusion protein comprises a linker between C 1 and TM and a linker between C 2 and TM.

12. The cell of claim 9 , wherein detectable moieties D 1 and D 2 are first and second affinity tags which are not the same.

13. The cell of claim 9 , wherein C 1 comprises a member of a library of candidate peptide substrates for an enzyme.

14. The cell of claim 9 , wherein at least one of detectable moieties D 1 and D 2 is a fluorescent protein.

15. The cell of claim 9 , wherein D 1 -C 1 is located at an N-terminal domain of the fusion protein and C 2 -D 2 is located at a C-terminal domain of the fusion protein.

16. The cell of claim 9 , wherein C 1 -D 1 is located at a C-terminal domain of the fusion protein and D 2 -C 2 is located at an N-terminal domain of the fusion protein.

17. A method for identifying a peptide substrate for an enzyme, the method comprising:

contacting a cell according to claim 1 with an enzyme; and

determining whether there is an increase in a D 2 signal from detectable moiety D 2 relative to a D 1 signal from detectable moiety D 1 , wherein an increase in the D 2 signal relative to the D 1 signal indicates that C 1 comprises a substrate for the enzyme.

18. A method for identifying an inhibitor for an enzyme, comprising:

contacting a cell according to claim 9 with an enzyme, wherein C 1 comprises a substrate for the enzyme and C 2 comprises a candidate inhibitor for the enzyme; and

detecting the presence or absence of a D 1 signal and a D 2 signal, wherein when C 1 comprises a substrate for the enzyme and C 2 comprises a candidate inhibitor for the enzyme, maintenance of the D 1 signal relative to the D 2 signal following contact with the enzyme indicates that C 2 comprises an inhibitor for the enzyme.

19. A method for identifying a peptide substrate for an enzyme, comprising:

contacting a cell according to claim 9 with an enzyme, wherein C 1 comprises an allosteric regulator for the enzyme and C 2 comprises a candidate substrate for the enzyme; and

determining whether there is a change in a D 2 signal from detectable moiety D 2 relative to a D 1 signal from detectable moiety D 1 , wherein a change in the D 2 signal relative to the D 1 signal indicates that C 2 comprises a substrate for the enzyme.

20. A method for identifying an allosteric regulator for an enzyme, comprising:

contacting a cell according to claim 9 with an enzyme, wherein C 1 comprises a known substrate for the enzyme and C 2 comprises a candidate allosteric regulator for the enzyme; and

determining whether there is a change in a D 2 signal from detectable moiety D 2 relative to a D 1 signal from detectable moiety D 1 , wherein a change in the D 2 signal relative to the D 1 signal indicates that C 2 comprises an allosteric regulator for the enzyme.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 8, 2014
From: UNIVERSITY OF CALIFORNIA SANTA BARBARA
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 033500/0905 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2013
From: DAUGHERTY, PATRICK SEAN; BOULWARE, KEVIN TODD
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 029747/0645 →
Continuity (4)
Continuation 12646323 · Dec 23, 2009
Continuation 11514377 · Aug 30, 2006
Provisional Application 60712434 · Aug 31, 2005
Related Publication 20130123141A1 · May 16, 2013